Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 5/20 | 0.54 |
| ▸ | PPARG | P37231 | 4/20 | 0.50 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | CTSS | P25774 | 3/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8893110 | 1.00 | PPARA (0.54) | PPARAPPARGACECTSSSYK | |
| SCHEMBL18241726 | 0.87 | SYK (0.54) | PPARAPPARGACECTSSSYK | |
| SCHEMBL18241722 | 0.86 | SYK (0.53) | PPARAPPARGACECTSSSYK | |
| SCHEMBL5639596 | 0.85 | PPARA (0.53) | PPARAPPARGACECTSSSYK | |
| SCHEMBL8562043 | 0.83 | PPARA (0.51) | PPARAPPARGACECTSSSYK | |
| SCHEMBL16731894 | 0.83 | SYK (0.52) | PPARAPPARGCTSSSYKCTSK | |
| SCHEMBL7947146 | 0.82 | MAPT (0.51) | PPARASYKCTSK | |
| SCHEMBL6757854 | 0.81 | MAPT (0.59) | — | |
| SCHEMBL10564283 | 0.81 | SYK (0.54) | PPARAPPARGCTSSSYKCTSK | |
| SCHEMBL376018 | 0.80 | PPARA (0.61) | PPARAPPARGACECTSSSYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5610141-A | CELL DIVISION STIMULANT | NYCOMED IMAGING AS (NO) | 1997-03-11 | — | — | US | disclosed |
| WO-1993024523-A1 | DOUBLE CHAIN PEPTIDE COMPOUNDS HAVING HEMOREGULATORY ACTIVITY | HAFSLUND NYCOMED AS (NO) | 1993-12-09 | — | — | WO | disclosed |